Every dollar of federal-funded research generates an additional $2.56 in economic activity. Because of the cuts by DOGE, people are going to die.

The new UK fund vehicle Reserved Investor Fund (RIF) is available beginning today, 19 March 2025. The RIF is available for ...

Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to ...

GATHER2 showed that some patients could get a benefit from the drug with dosing every other month, and also that there were benefits to continuing treatment ... in its current form by today's ...

Auburn football head coach Hugh Freeze was diagnosed with an "early form of prostate cancer," the ... and with forthcoming proper treatment, is expected to make a full recovery.

Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, with outbreaks continuing to emerge globally and domestically ... proportion in almost any body part. This latter form, ...

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

The approval of iptacopan in reducing proteinuria in adult patients with native kidney C3G was based on data from the randomized, double-blind, placebo-controlled, phase 3 APPEAR-C3G trial.

Authors Key Points Media Contact For general and media inquiries and to book our experts, please contact: [email protected] Background About 40.3 million Americans have a substance use disorder (SUD).

TIL therapy is FDA-approved as a second or third option for patients with advanced melanoma. Gibney said in the future, the ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...